<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Subcutaneous infiltration of local anesthetics</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Subcutaneous infiltration of local anesthetics</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Subcutaneous infiltration of local anesthetics</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Deborah C Hsu, MD, MEd</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anne M Stack, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ron M Walls, MD, FRCPC, FAAEM</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stanley J Miller, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 18, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The subcutaneous infiltration of local anesthetics for minor skin procedures (eg, wound repair, lumbar puncture, or insertion of vascular catheters) will be reviewed here.</p><p>Topical anesthetics in children, peripheral nerve blocks, and regional anesthesia are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/6338.html" rel="external">"Clinical use of topical anesthetics in children"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14929.html" rel="external">"Clinical use of local anesthetics in anesthesia"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/397.html" rel="external">"Overview of peripheral nerve blocks"</a> and  <a class="medical medical_review" href="/z/d/html/399.html" rel="external">"Overview of anesthesia", section on 'Peripheral nerve blocks'</a> and  <a class="medical medical_review" href="/z/d/html/262.html" rel="external">"Digital nerve block"</a>.)</p><p></p><p class="headingAnchor" id="H2693192"><span class="h1">ANATOMY AND PHYSIOLOGY</span><span class="headingEndMark"> — </span>The skin is made up of the epidermis and dermis. The subcutaneous layer lies beneath the dermis  (<a class="graphic graphic_figure graphicRef54157" href="/z/d/graphic/54157.html" rel="external">figure 1</a>). Direct infiltration of local anesthetic into the subcutaneous layer effectively blocks pain transmission from the free nerve endings located in the epidermal and dermal layers [<a href="#rid1">1</a>]. Intradermal injection is also effective but more painful than subcutaneous injection.</p><p>Local anesthetics reversibly block sodium channels within the nerve fibers, which prevents transmission of pain signals by disrupting depolarization of the nerve [<a href="#rid2">2</a>]. Pain fibers are relatively unmyelinated when compared with afferent fibers that transmit the sensation of touch or temperature or nerves that control muscle contraction. Thus, infiltration of dilute solutions of local anesthetics near the nerve fibers produces relief of pain with less interruption in the sense of touch or temperature and without muscle paralysis in most children and adults. Because myelin sheaths throughout the nervous system are not fully developed in neonates and young infants, even dilute solutions of local anesthetics have a higher potential for producing muscle paralysis and central toxicity in such patients [<a href="#rid3">3</a>]. </p><p>Local anesthetics are weak organic bases that are composed of charged and uncharged forms when in solution [<a href="#rid3">3-5</a>]. Only the uncharged forms are thought to be capable of diffusion through interstitial tissues and transport across the nerve membrane [<a href="#rid6">6</a>]. Dispersion of the local anesthetic through the tissue occurs more rapidly as the percentage of uncharged form increases [<a href="#rid4">4</a>]. The pH of the solution and the surrounding tissues and the pKa of the specific agent determine the proportion of charged and uncharged anesthetic. Increased acidity of the solution or of the tissues (eg, infected skin) reduces the proportion of anesthetic in the uncharged form according to Henderson-Hasselbalch equation as follows [<a href="#rid3">3,6</a>]:</p><div class="formulaContainer"><div class="formula"><p>[Charged anesthetic]          (pKa-pH)<br/>___________________ = 10<br/><br/>[Uncharged anesthetic]</p></div></div><p>Most local anesthetic solutions are marketed in acidic forms with pH of 5.0 to 7.0. The anesthetic is more stable in this pH range and has a shelf life of three to four years at room temperature [<a href="#rid4">4</a>]. For some formulations, the pH of the anesthetic solution is increased to 7.2 to 7.4 (physiologic pH) by the addition of <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a>. This results in a greater proportion of anesthetic being in the uncharged form, thereby enhancing the analgesic effect and decreasing the pain of injection [<a href="#rid3">3,4,7</a>]. (See <a class="local">'Methods to decrease injection pain'</a> below.)</p><p>However, once the pH is increased, the buffered <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> is more susceptible to photodegradation, aldehyde formation, and other denaturing reactions, leading to a shelf life of one to three weeks at room temperature [<a href="#rid4">4,8</a>]. This buffering approach cannot be used for some agents (eg, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>) because they will precipitate at physiologic pH [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H2383286244"><span class="h1">CLASSIFICATION OF LOCAL ANESTHETICS</span><span class="headingEndMark"> — </span>Most local anesthetics are classified as amides or esters  (<a class="graphic graphic_table graphicRef57120" href="/z/d/graphic/57120.html" rel="external">table 1</a>) [<a href="#rid9">9,10</a>]. Local anesthetics in the amide class include <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (the most commonly used agent), <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">mepivacaine</a>, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, etidocaine, <a class="drug drug_general" data-topicid="10228" href="/z/d/drug information/10228.html" rel="external">prilocaine</a>, <a class="drug drug_general" data-topicid="9873" href="/z/d/drug information/9873.html" rel="external">ropivacaine</a>, and levobupivacaine [<a href="#rid2">2,10</a>]. Common ester agents include procaine (Novocaine), 2-chloroprocaine, <a class="drug drug_general" data-topicid="10278" href="/z/d/drug information/10278.html" rel="external">tetracaine</a>, cocaine, and <a class="drug drug_general" data-topicid="9092" href="/z/d/drug information/9092.html" rel="external">benzocaine</a> [<a href="#rid2">2</a>]. Because of toxicity and allergic reactions, the ester agents have <strong>limited</strong> indications for local infiltration, except in patients with allergy to amide agents [<a href="#rid2">2,11</a>]. (See  <a class="medical medical_review" href="/z/d/html/14929.html" rel="external">"Clinical use of local anesthetics in anesthesia"</a>.)</p><p class="headingAnchor" id="H2693871"><span class="h1">CHOICE OF ANESTHETIC</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a>, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>, <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">mepivacaine</a>, and procaine are the most commonly used agents for subcutaneous infiltration of local anesthesia [<a href="#rid12">12,13</a>]. The comparative properties of lidocaine, bupivacaine, procaine, and mepivacaine are provided in the table and can affect the choice of anesthetic in particular situations  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>). A history of allergy to specific anesthetics or specific additives (eg, methylparaben, metabisulfite) contained in different formulations of the same anesthetic may also impact the choice of agent.</p><p class="headingAnchor" id="H2"><span class="h2">Lidocaine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> is a local anesthetic in the amide class and is the most commonly used anesthetic for local infiltration.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preparation</strong> – <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> is usually given as a 1 percent solution (10 mg/mL). If large volumes are needed or a smaller dose is desired, the clinician may use a 0.5 percent solution. Higher concentrations of lidocaine beyond 1 percent do not promote improved onset or duration of analgesia and may increase the risk of toxicity [<a href="#rid12">12</a>]. Buffering of lidocaine with <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> (as described in the preceding section) decreases the pain of injection, especially when using lidocaine with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, and may shorten the time to anesthetic effect [<a href="#rid12">12</a>]. (See <a class="local">'Methods to decrease injection pain'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dose </strong>– The dose of <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> should <strong>not exceed </strong>the following [<a href="#rid5">5,14,15</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> <strong>without</strong> <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> (also called plain lidocaine) – 5 mg/kg (0.5 mL/kg of lidocaine 1 percent, maximum total dose: 300 mg [30 mL of lidocaine 1 percent])</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> <strong>with</strong> <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> – 7 mg/kg (0.7 mL/kg of lidocaine 1 percent, maximum total dose: 500 mg [50 mL of lidocaine 1 percent with epinephrine]).</p><p></p><p class="bulletIndent2">For an added margin of safety, 80 percent of the maximum allowable dose should be used in children under eight years of age [<a href="#rid1">1</a>]. In addition, because anesthetics in the amide class are metabolized by the liver and excreted by the kidneys, the total dose of <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> should be decreased by approximately 50 percent in older adults with severe liver or kidney disease [<a href="#rid7">7,16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Onset of action and duration of anesthesia</strong> – The onset of anesthesia typically occurs within two to five minutes, and the duration of anesthesia varies from 30 minutes to two hours for plain <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, which is long enough to complete most procedures [<a href="#rid7">7,17,18</a>]. The addition of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> (available premixed at concentrations of 1:100,000 or 1:200,000) provides local vasoconstriction which prolongs the duration of action  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>), decreases local bleeding during the procedure, and reduces systemic lidocaine absorption [<a href="#rid17">17</a>]. In addition, this combination may extend the duration of anesthesia up to three hours [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1">The concentration of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> may be diluted to less than 1:200,000 by mixing plain <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> and lidocaine with epinephrine in patients who are sensitive to catecholamine injection [<a href="#rid18">18</a>]. Concentrations as low as 1:1,000,000 still maintain effective vasoconstriction. However, this dilution does decrease the duration of action, may allow for greater systemic absorption, and may increase the amount of local bleeding. (See <a class="local">'Catecholamine sensitivity'</a> below.)</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> may be used in the face (including the nose and ear), digit, or penis [<a href="#rid18">18</a>]. In the past, injection of epinephrine with local anesthetic was discouraged in these sites. However, there is no convincing evidence of harm with such use. As an example, comprehensive reviews of the medical literature and large observational studies have failed to find any reports of gangrene or major ischemic complications solely attributable to lidocaine with epinephrine. (See  <a class="medical medical_review" href="/z/d/html/262.html" rel="external">"Digital nerve block", section on 'Use of epinephrine'</a>.)</p><p></p><p><a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">Lidocaine</a> with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> should be <strong>avoided</strong> for digital anesthesia in patients with peripheral artery disease [<a href="#rid18">18</a>]. (See <a class="local">'Contraindications'</a> below.) </p><p class="headingAnchor" id="H9"><span class="h2">Bupivacaine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">Bupivacaine</a> is an amide anesthetic that is more potent and has a longer duration of action than <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">mepivacaine</a>, or procaine [<a href="#rid2">2,10</a>]. The increases in potency and duration of action are related to prolonged binding of sodium channels. Thus, if systemically absorbed, bupivacaine has a higher risk of major toxicity (eg, seizures, intractable cardiac arrhythmias) than lidocaine and most other local anesthetics [<a href="#rid3">3</a>]. Bupivacaine is contraindicated for local infiltration in pregnant women [<a href="#rid2">2,10</a>], and should be infiltrated with caution in acutely ill, debilitated, or older adult patients.</p><p><a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">Bupivacaine</a> is a good choice for longer procedures, for patients who have contraindications to <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> injection, for situations where there will be a delay between infiltration of local anesthetic and the procedure, or for instances in which prolonged post-procedure pain control is preferred.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preparation</strong> – <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">Bupivacaine</a> is commercially available in concentrations of 0.25 percent (2.5 mg/mL) and 0.5 percent (5 mg/mL). The lower concentration should be used in awake patients because local infiltration with 0.5 percent bupivacaine is painful. Unlike <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, buffering with <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> does not reduce the pain of injection and may lead to precipitation of the active drug [<a href="#rid2">2</a>]. (See <a class="local">'Methods to decrease injection pain'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dose</strong> – The dose of <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> should <strong>not</strong> <strong>exceed</strong> the following [<a href="#rid12">12</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">Bupivacaine</a> <strong>without</strong> <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> – 2 mg/kg (0.8 mL/kg of bupivacaine 0.25 percent, maximum total dose: 175 mg [70 mL of bupivacaine 0.25 percent])</p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">Bupivacaine</a> <strong>with</strong> <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> – 3 mg/kg (1.2 mL/kg of bupivacaine 0.25 percent, maximum total dose: 225 mg [90 mL of bupivacaine 0.25 percent with epinephrine])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Onset of action and duration of anesthesia</strong> – The onset of action of <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> is 5 to 10 minutes and the duration of effect is up to six hours  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>) [<a href="#rid12">12</a>]. The addition of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> does not increase the duration of anesthetic effect but may decrease systemic absorption, and use may be desirable for hemostatic purposes [<a href="#rid2">2,3</a>].</p><p></p><p class="headingAnchor" id="H2694061"><span class="h2">Mepivacaine</span><span class="headingEndMark"> — </span><a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">Mepivacaine</a>, an amide local anesthetic, is an alternative to <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, although it is less commonly used. Systemic toxicity is similar to that of lidocaine [<a href="#rid2">2,10</a>]. Pregnancy is a relative contraindication to the use of mepivacaine because of poor fetal metabolism related to hepatic immaturity [<a href="#rid2">2</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preparation</strong> – <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">Mepivacaine</a> is usually administered as a 1 percent (10 mg/mL) solution. A 0.5 percent (5 mg/mL) solution is also commercially available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dose</strong> – The dose of <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">mepivacaine</a> should <strong>not exceed </strong>the following [<a href="#rid18">18</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">Mepivacaine</a> <strong>without</strong> <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> – 5 mg/kg (0.5 mL/kg of mepivacaine 1 percent, maximum total dose 300 mg [30 mL of mepivacaine 1 percent])</p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">Mepivacaine</a> <strong>with</strong> <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> – 7 mg/kg (0.7 mL/kg of mepivacaine 1 percent, maximum total dose 500 mg [50 mL of mepivacaine 1 percent with epinephrine])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Onset of action and duration of anesthesia </strong>– Similar to <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, <a class="drug drug_general" data-topicid="9610" href="/z/d/drug information/9610.html" rel="external">mepivacaine</a> has an onset of action of two to five minutes and duration of anesthesia lasting up to two hours. [<a href="#rid2">2,9</a>]. Addition of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> increases the duration of action up to three hours [<a href="#rid10">10,18</a>].</p><p></p><p class="headingAnchor" id="H2693989"><span class="h2">Procaine</span><span class="headingEndMark"> — </span>Procaine (Novocaine) is an ester anesthetic. Its primary use is in patients undergoing dental procedures and those with allergy to amide anesthetics [<a href="#rid12">12</a>]. When compared with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, procaine has a longer time to onset of action, shorter duration of action, and poor penetrating ability [<a href="#rid3">3</a>]. However, it has very little systemic toxicity.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preparation</strong> – Procaine is typically administered as a 1 percent (10 mg/mL) solution. A 0.5 percent (5 mg/mL) solution is also commercially available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dose </strong>– The dose of procaine should <strong>not exceed</strong> the following [<a href="#rid12">12,18</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Procaine <strong>without</strong> <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> – 7 mg/kg (0.7 mL/kg of procaine 1 percent, maximum total dose 500 mg [50 mL of procaine 1 percent])</p><p class="bulletIndent2"><span class="glyph">•</span>Procaine <strong>with</strong> <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> – 9 mg/kg (0.9 mL/kg of procaine 1 percent, maximum total dose 600 mg [60 mL of procaine 1 percent with epinephrine])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Onset of action and duration of anesthesia</strong> – Procaine has an onset of action of 5 to 10 minutes and duration of anesthesia of up to 1.5 hours.</p><p></p><p class="headingAnchor" id="H2694362"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>Infiltration of local anesthesia is effective for pain control during a variety of procedures, including skin surgery (eg, skin biopsy, scar revision, small skin grafts), open wound repair, abscess drainage, foreign body removal from the skin, vascular access procedures, and lumbar puncture [<a href="#rid12">12,18,19</a>]. The choice of agent depends on several factors, including the duration of the procedure, need for hemostasis, patient sensitivity to catecholamines, and patient allergy to local anesthetics  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>). (See <a class="local">'Choice of anesthetic'</a> above.)</p><p>In children, we suggest initial pain control with topical LET (<a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>, <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, <a class="drug drug_general" data-topicid="10278" href="/z/d/drug information/10278.html" rel="external">tetracaine</a>) rather than infiltrative anesthesia for uncomplicated facial or scalp lacerations. Children should also receive some form of topical analgesia prior to venipuncture, intravenous catheter placement, or Port-A-Cath access unless emergency testing or access is necessary. (See  <a class="medical medical_review" href="/z/d/html/6338.html" rel="external">"Clinical use of topical anesthetics in children", section on 'Summary and recommendations'</a> and  <a class="medical medical_review" href="/z/d/html/6338.html" rel="external">"Clinical use of topical anesthetics in children", section on 'Lidocaine-epinephrine-tetracaine (LET)'</a>.)</p><p class="headingAnchor" id="H2694370"><span class="h1">CONTRAINDICATIONS</span><span class="headingEndMark"> — </span>True allergy to a local anesthetic is a contraindication for use of that anesthetic and other agents with the same chemical classification (ie, amide or ester)  (<a class="graphic graphic_table graphicRef57120" href="/z/d/graphic/57120.html" rel="external">table 1</a>). In contrast, local administration of an anesthetic with a different chemical classification is safe in most instances, as long as prior administration was not associated with generalized urticaria or anaphylaxis. If the procedure is elective, it is optimal to have the patient evaluated by an allergist prior to the procedure to assist in distinguishing allergy to the local anesthetic from allergy to other chemical additives (eg, methylparaben) and to help differentiate an allergic reaction from other types of adverse reactions commonly associated with infiltration of local anesthetics. (See  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics", section on 'Management algorithm for nonallergy clinicians'</a>.)</p><p>Infiltration of local anesthetics is not recommended for the management of large or multiple lacerations where the total dose needed for adequate effect is expected to be close to the maximum allowable anesthetic dose  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>) [<a href="#rid12">12</a>]. In such situations, a regional block or Bier (IV regional) block may be performed instead.</p><p>A regional block may be preferable to infiltration of local anesthetic for repair of wounds that require precise anatomic alignment (eg, lacerations through the vermillion border of the lip) because local infiltration might distort important skin landmarks [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/397.html" rel="external">"Overview of peripheral nerve blocks"</a>.)</p><p>The clinician should <strong>not</strong> use <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> with local anesthetic infiltration in the following settings [<a href="#rid18">18</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Large wounds in patients with underlying conditions (eg, hyperthyroidism, pheochromocytoma, severe hypertension, coronary artery disease) that may be exacerbated by systemic <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> effects.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Digital anesthesia in patients with compromised digital circulation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Periorbital infiltration in patients with narrow angle glaucoma</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with catecholamine sensitivity (see <a class="local">'Catecholamine sensitivity'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients taking <a class="drug drug_general" data-topicid="16085" href="/z/d/drug information/16085.html" rel="external">lurasidone</a> (may cause hypotension, category X drug interaction [avoid combination])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients taking ergot alkaloids, such as <a class="drug drug_general" data-topicid="9416" href="/z/d/drug information/9416.html" rel="external">ergotamine</a> (enhanced hypertensive and vasoconstrictive effect, category X drug interaction [avoid combination])</p><p></p><p><a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">Epinephrine</a> infiltration with local anesthetics has the potential for enhancing hypertensive effects when combined with the following medications which may warrant lower dosing of epinephrine (eg, mixing <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> with epinephrine 1:1 with plain lidocaine) [<a href="#rid18">18</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Beta blockers (less risk with cardioselective medications, category D drug interaction, consider therapy modification)</p><p class="bulletIndent1"><span class="glyph">●</span>Monoamine oxidase inhibitors (category C drug interaction, monitor therapy)</p><p class="bulletIndent1"><span class="glyph">●</span>Phenothiazines (category D drug interaction, consider therapy modification)</p><p class="bulletIndent1"><span class="glyph">●</span>Tricyclic antidepressants (category D drug interaction, consider therapy modification)</p><p></p><p class="headingAnchor" id="H2694386"><span class="h1">PREPARATION</span><span class="headingEndMark"> — </span>The clinician should determine the patient’s prior experience with local anesthesia and if allergies or adverse reactions have occurred. The patient and family/caregiver(s) should receive an explanation of the planned approach. A child life specialist or other personnel are often helpful in reducing the anxiety of children undergoing painful procedures. Procedural sedation may be necessary in addition to infiltration of local anesthesia for certain patients (eg, young children or anxious older patients) who are undergoing cosmetic laceration repairs or other procedures (eg, central venous access, lumbar puncture) that require complete patient cooperation. (See  <a class="medical medical_review" href="/z/d/html/6330.html" rel="external">"Procedural sedation in children: Approach"</a> and  <a class="medical medical_review" href="/z/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications"</a>.)</p><p class="headingAnchor" id="H343901"><span class="h2">History of adverse reaction</span><span class="headingEndMark"> — </span>Clinical situations may arise in which local anesthesia is required for a patient with a history of a prior adverse reaction to a specific local anesthetic. True IgE-mediated allergic reactions to local anesthetic agents are rare, but convincing case reports do exist. The approach to patients with a history of prior adverse reactions to local anesthetics depends upon the specific history and is provided in the algorithm  (<a class="graphic graphic_algorithm graphicRef117594" href="/z/d/graphic/117594.html" rel="external">algorithm 1</a>) (see  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonallergic reaction</strong> – If a local anesthetic is needed in a patient with a past adverse reaction, the patient's past signs and symptoms should be reviewed along with any procedures that were performed with local anesthesia since the adverse reaction (eg, dental procedures). If the reaction can be specifically identified as something other than allergy (eg, catecholamine sensitivity, systemic toxicity, vasovagal syncope), then the clinician should focus on strategies that specifically limit anxiety, pain, total dose of anesthetic administered, or catecholamine exposure. (See <a class="local">'Methods to decrease injection pain'</a> below and <a class="local">'Lidocaine'</a> above and  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics", section on 'Patients with past nonallergic reactions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contact dermatitis</strong> – If the reaction consists of contact dermatitis or delayed local swelling, it is reasonable to proceed with the use of a local anesthetic from the <strong>other</strong> group (ester or amide)  (<a class="graphic graphic_table graphicRef57120" href="/z/d/graphic/57120.html" rel="external">table 1</a>). In most cases, patients with type IV allergic reactions are tolerant of a local anesthetic chosen from the group of agents to which they did not react. As an example, a patient with past possible allergy to procaine (group I) would be predicted to tolerate <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> (group II) in most cases. In addition, it is prudent to use a preservative-free formulation that does not contain metabisulfites or methylparaben in patients with type IV allergic reactions to local anesthetics. Patch testing prior to the procedure is ideal. (See  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anaphylaxis or other life-threatening reaction</strong> – Patients who report a history of symptoms that are suggestive of anaphylaxis (ie, diffuse hives, wheezing, throat closure) or any other life-threatening reaction should <strong>not</strong> receive local anesthetics until they undergo a complete evaluation by an allergy specialist. If the procedure is elective, it should be deferred until this evaluation has occurred. If the procedure is urgent, then the patient should receive an alternative to local anesthesia (eg, procedural sedation). (See  <a class="medical medical_review" href="/z/d/html/6330.html" rel="external">"Procedural sedation in children: Approach"</a> and  <a class="medical medical_review" href="/z/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications"</a>.)</p><p></p><p>The evaluation of possible allergy to local anesthetics is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics"</a>.)</p><p class="headingAnchor" id="H540456"><span class="h2">Materials</span><span class="headingEndMark"> — </span>The clinician should assemble the following items:</p><p class="bulletIndent1"><span class="glyph">●</span>Povidone-iodine or <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a> solution</p><p class="bulletIndent1"><span class="glyph">●</span>Sterile gauze</p><p class="bulletIndent1"><span class="glyph">●</span>Sterile gloves</p><p class="bulletIndent1"><span class="glyph">●</span>25-, 27-, or 30-gauge long (1.5 inch) hypodermic needle</p><p class="bulletIndent1"><span class="glyph">●</span>Syringe (1 ,3, 5, 6, or 10 mL) </p><p class="bulletIndent1"><span class="glyph">●</span>Local anesthetic agent (see <a class="local">'Choice of anesthetic'</a> above)</p><p></p><p class="headingAnchor" id="H2694394"><span class="h1">PROCEDURE</span></p><p class="headingAnchor" id="H540550"><span class="h2">Methods to decrease injection pain</span><span class="headingEndMark"> — </span>When <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> injection is used for local anesthesia during urgent or routine procedures, we suggest buffering with <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> and warming the anesthetic agent to approximately body temperature (37°C) prior to injection. In a systematic review and meta-analysis of randomized trials that assessed pain of local buffered lidocaine injection in children and adults (7 parallel-group studies, n = 635 patients; 10 crossover studies, n = 432 patients), buffered lidocaine decreased the pain of injection compared with unbuffered lidocaine, although the effect was modest (pooled pain reduction 2 out of 10 pain units in crossover studies [95% CI -2.6 to -1.3 units] and 1 out of 10 pain units in parallel trials [95% CI -1.4 to -0.5]) [<a href="#rid20">20</a>].</p><p>In a meta-analysis of 18 randomized or pseudo-randomized trials (over 830 patients), warming of <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> to body temperature prior to injection significantly decreased pain (mean difference -11 mm on a 100-mm scale) [<a href="#rid21">21</a>]. .</p><p>The standard solutions of plain <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> or commercially prepared lidocaine with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> have pH values of 5.0 to 7.0 and 3.0 to 5.0 [<a href="#rid2">2,22</a>]. These preparations can be buffered by adding one part of 1 mEq/mL of <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> to 9 or 10 parts of 1 percent lidocaine or lidocaine with epinephrine. The shelf life of buffered plain lidocaine is approximately one week [<a href="#rid8">8</a>]. However, the addition of bicarbonate to lidocaine with epinephrine inactivates epinephrine within 24 hours. Thus, when using multidose vials of lidocaine, it is best to buffer it by drawing the appropriate volumes of sodium bicarbonate and lidocaine into the syringe rather than injecting sodium bicarbonate into the vial.</p><p>Several other techniques may decrease the pain associated with injection. They include [<a href="#rid1">1,12,18</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Patient distraction (eg, television, mental imagery, and in children, books or toys [eg, pinwheel, blowing bubbles])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gentle pinching or vibration adjacent to the site of injection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of small needles (25-, 27-, or 30-gauge)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Slow rate of injection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Subcutaneous instead of intradermal injection</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reducing pressure of injection by using small volume syringes (eg, 1 or 3 mL)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Injecting with a needle angle of 90 rather than 45 degrees when penetrating intact skin for elective procedures (eg, skin biopsy) [<a href="#rid23">23</a>]</p><p></p><p class="headingAnchor" id="H343150"><span class="h2">Technique</span><span class="headingEndMark"> — </span>Intact, uninfected skin and clean lacerations may undergo direct infiltration. Heavily contaminated lacerations or skin abscesses should undergo a field block.</p><p class="headingAnchor" id="H343175"><span class="h3">Direct infiltration</span><span class="headingEndMark"> — </span>The steps for direct infiltration of local anesthetic are as follows [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>For lacerations, ensure that the areas distal to the wound show no neurovascular compromise.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Explain the procedure to the patient and, in children, the caregiver.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Provide sedation and restraint, as needed (eg, children or other potentially uncooperative patients). (See  <a class="medical medical_review" href="/z/d/html/6330.html" rel="external">"Procedural sedation in children: Approach"</a> and  <a class="medical medical_review" href="/z/d/html/264.html" rel="external">"Procedural sedation in adults in the emergency department: General considerations, preparation, monitoring, and mitigating complications"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cleanse the site of infiltration with povidone-iodine or <a class="drug drug_general" data-topicid="9244" href="/z/d/drug information/9244.html" rel="external">chlorhexidine</a> solution or other similar antiseptic preparation and allow to air dry or dry with sterile gauze. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hide the needle from view prior to and during injection, especially in children.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For open wounds, put a few drops of anesthetic into the wound and then immediately place the needle into the subcutaneous layer  (<a class="graphic graphic_figure graphicRef54157" href="/z/d/graphic/54157.html" rel="external">figure 1</a>) by inserting it through the wound margin rather than intact skin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For intact skin, rapidly insert the needle through the skin into the subcutaneous layer  (<a class="graphic graphic_figure graphicRef54157" href="/z/d/graphic/54157.html" rel="external">figure 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Slowly inject small volumes of anesthetic. During anesthetic infiltration, either slowly advance the needle or initially insert it to the hub and infiltrate as the needle is withdrawn. Aspiration is not necessary prior to each infiltration unless the area undergoing local anesthesia is close to major blood vessels.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anesthetize adjacent areas by inserting the needle through the previously injected skin or wound until the entire region requiring anesthesia is infiltrated. This is ordinarily accomplished in a linear laceration, for example, by entering the proximal portion of the wound and administering <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> as one proceeds forward or by moving the needle forward to the distal end of the wound and withdrawing back to the original point while injecting lidocaine. The clinician should know where the last portion of anesthesia was delivered and insert the needle in that area if additional injections are required to avoid subjecting patients to additional pain from repeated insertion of the needle into unanesthetized areas.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After a few minutes, lightly test the skin or wound margins for adequate anesthesia using the injection needle or other sharp object (suture needle, Adson forceps). Timing of complete and optimal anesthesia will depend upon the local anesthetic that is used  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>).</p><p></p><p class="headingAnchor" id="H343182"><span class="h3">Field block</span><span class="headingEndMark"> — </span>For heavily contaminated wounds or when anesthetizing for incision and drainage of a skin abscess, prepare the patient and wound in the same way as for direct infiltration [<a href="#rid1">1</a>]. (See <a class="local">'Direct infiltration'</a> above.)</p><p>Procedural sedation may also be necessary to ensure proper wound decontamination in a relatively painless manner. Alternatively, a regional block may be performed. (See  <a class="medical medical_review" href="/z/d/html/397.html" rel="external">"Overview of peripheral nerve blocks"</a>.)</p><p>Proceed with the field block as follows:</p><p class="bulletIndent1"><span class="glyph">●</span>Insert the needle into the subcutaneous layer through intact, clean skin along the margin of the contaminated wound or through uninfected skin immediately adjacent to the abscess.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Slowly inject small volumes of anesthetic taking care to monitor the total dose administered. During anesthetic infiltration, either slowly advance the needle or initially insert it to the hub, and infiltrate as the needle is withdrawn. Aspiration is not necessary prior to each infiltration, unless the area undergoing local anesthesia is close to major blood vessels.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reinsert the needle through the area just anesthetized, redirecting it along the margins of the wound or circumferentially around the abscess and infiltrate additional anesthetic.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Continue infiltration through previously injected skin until the entire region requiring anesthesia is infiltrated.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>After a few minutes, lightly test the skin or wound margins for adequate anesthesia using the injection needle or other sharp object (suture needle, Adson forceps). Timing of complete and optimal anesthesia will depend upon the local anesthetic that is used  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>).</p><p></p><p class="headingAnchor" id="H2694410"><span class="h1">FOLLOW-UP CARE</span><span class="headingEndMark"> — </span>The patient, and in children, the caretaker, should be advised that full recovery of sensation in the anesthetized region is expected soon after the procedure. The exact timing of recovery will depend upon the anesthetic used  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>). Until full sensation has returned, the patient should be told that the region is prone to inadvertent injury, including thermal injury from excessive heat or cold exposure.</p><p class="headingAnchor" id="H13"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>Complications during infiltration of local anesthetics are rare. Avoidance of intravascular injection into major vessels and care not to exceed the maximum total dose of anesthetic helps to avoid complications in most patients.</p><p class="headingAnchor" id="H2694642"><span class="h2">Systemic toxicity</span><span class="headingEndMark"> — </span>Systemic toxicity following subcutaneous local anesthetic infiltration may manifest as (see  <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">"Local anesthetic systemic toxicity", section on 'Differences in toxicity among local anesthetics'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Central nervous system effects including: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Metallic taste</p><p class="bulletIndent2"><span class="glyph">•</span>Tinnitus</p><p class="bulletIndent2"><span class="glyph">•</span>Tingling of the lips</p><p class="bulletIndent2"><span class="glyph">•</span>Dizziness</p><p class="bulletIndent2"><span class="glyph">•</span>Anxiety</p><p class="bulletIndent2"><span class="glyph">•</span>Agitation</p><p class="bulletIndent2"><span class="glyph">•</span>Confusion</p><p class="bulletIndent2"><span class="glyph">•</span>Lethargy</p><p class="bulletIndent2"><span class="glyph">•</span>Loss of consciousness</p><p class="bulletIndent2"><span class="glyph">•</span>Seizures</p><p></p><p class="bulletIndent2"><strong>and/or</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular effects including:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bradycardia</p><p class="bulletIndent2"><span class="glyph">•</span>Decreased myocardial contractility</p><p class="bulletIndent2"><span class="glyph">•</span>Atrioventricular block</p><p class="bulletIndent2"><span class="glyph">•</span>Vasodilation</p><p class="bulletIndent2"><span class="glyph">•</span>Ventricular arrhythmias</p><p class="bulletIndent2"><span class="glyph">•</span>Cardiac arrest</p><p></p><p>Although an usual event, systemic toxicity can occur if the recommended local anesthetic dose is exceeded  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>), if a major vessel is inadvertently injected with a large amount of anesthetic, or as an idiosyncratic response. Among the local anesthetics commonly infiltrated, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> has the greatest potential for systemic toxicity.</p><p class="headingAnchor" id="H14845728"><span class="h3">Treatment</span><span class="headingEndMark"> — </span>The management of local anesthetic systemic toxicity is provided in the rapid overview  (<a class="graphic graphic_table graphicRef107887" href="/z/d/graphic/107887.html" rel="external">table 3</a>) and is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">"Local anesthetic systemic toxicity", section on 'Management of LAST'</a>.)</p><p class="headingAnchor" id="H2694354"><span class="h2">Catecholamine sensitivity</span><span class="headingEndMark"> — </span>Tachycardia, hypertension, palpitations, and anxiety (eg, a sense of doom) may accompany subcutaneous injection of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a> in sensitive patients or inadvertent intravascular injection in normal patients [<a href="#rid18">18</a>].</p><p class="headingAnchor" id="H345706"><span class="h2">Vasovagal syncope</span><span class="headingEndMark"> — </span>Vasovagal (also called neurocardiogenic) syncope is usually associated with bradycardia (rather than tachycardia) and pallor (rather than flushing). These differences can be helpful in distinguishing it from anaphylaxis. (See  <a class="medical medical_review" href="/z/d/html/1050.html" rel="external">"Reflex syncope in adults and adolescents: Clinical presentation and diagnostic evaluation"</a>.)</p><p class="headingAnchor" id="H344652"><span class="h2">Allergic reaction</span><span class="headingEndMark"> — </span>Two different types of allergic reactions to local anesthetics have been described:</p><p class="bulletIndent1"><span class="glyph">●</span>Allergic contact dermatitis and delayed swelling at the site of administration – Affected patients develop a localized eczematous and pruritic rash within 72 hours at the site of local anesthetic administration. Vesiculation, blistering, and/or weeping can occur. The affected area is limited to tissue that was in direct contact with the anesthetic. Treatment is as for other types of contact dermatitis. (See  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics", section on 'Rare: Delayed reactions (contact dermatitis or local swelling)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urticaria and anaphylaxis – These types of reaction are rare and the data implicating local anesthetics are limited to case reports. Patients who display signs of acute anaphylaxis (eg, hives, facial or intraoral swelling, stridor, wheezing, hypotension)  (<a class="graphic graphic_table graphicRef66333" href="/z/d/graphic/66333.html" rel="external">table 4</a>) should receive emergent treatment  (<a class="graphic graphic_table graphicRef58346" href="/z/d/graphic/58346.html" rel="external">table 5</a> and <a class="graphic graphic_table graphicRef74242" href="/z/d/graphic/74242.html" rel="external">table 6</a>). (See  <a class="medical medical_review" href="/z/d/html/392.html" rel="external">"Anaphylaxis: Emergency treatment"</a> and  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics", section on 'Rare: Immediate reactions (urticaria and anaphylaxis)'</a>.)</p><p></p><p class="headingAnchor" id="H3443328830"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/129632.html" rel="external">"Society guideline links: Local and regional anesthesia"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/129826.html" rel="external">"Society guideline links: Local anesthetic systemic toxicity"</a>.)</p><p class="headingAnchor" id="H248870889"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/16246.html" rel="external">"Patient education: Anesthesia (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2694419"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications and choice of local anesthetic</strong> – Infiltration of local anesthesia is effective for pain control during a variety of procedures, including (see <a class="local">'Indications'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Open wound repair </p><p class="bulletIndent2"><span class="glyph">•</span>Skin surgery (eg, skin biopsy, scar revision, small skin grafts) </p><p class="bulletIndent2"><span class="glyph">•</span>Abscess drainage </p><p class="bulletIndent2"><span class="glyph">•</span>Foreign body removal from the skin </p><p class="bulletIndent2"><span class="glyph">•</span>Vascular access procedures</p><p class="bulletIndent2"><span class="glyph">•</span>Lumbar puncture </p><p></p><p class="bulletIndent1">Characteristics of agents commonly used for local anesthetic infiltration are summarized in the table  (<a class="graphic graphic_table graphicRef56799" href="/z/d/graphic/56799.html" rel="external">table 2</a>). The choice of local anesthetic for infiltration depends on several factors, including duration of the procedure, need for hemostasis, patient sensitivity to catecholamines, and patient allergy to local anesthetics. (See <a class="local">'Choice of anesthetic'</a> above.)</p><p></p><p class="bulletIndent1">For most procedures and for most patients, <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> is a good choice. (See <a class="local">'Lidocaine'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Contraindications</strong> – Local anesthetic infiltration is contraindicated in the following instances (see <a class="local">'Contraindications'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The amount of anesthetic needed to provide adequate analgesia exceeds the maximal safe total dose.</p><p class="bulletIndent2"><span class="glyph">•</span>The patient has had generalized urticaria or anaphylaxis in association with administration of local anesthesia and has not undergone evaluation by an allergy subspecialist.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with prior adverse reactions</strong> – Prior to infiltration, the clinician should determine if the patient has any history of allergy or adverse reaction associated with receiving local anesthesia. The approach to patients with a history of prior adverse reactions to local anesthetics depends upon the specific history; an approach is provided in the algorithm  (<a class="graphic graphic_algorithm graphicRef117594" href="/z/d/graphic/117594.html" rel="external">algorithm 1</a>). (See <a class="local">'History of adverse reaction'</a> above and  <a class="medical medical_review" href="/z/d/html/2084.html" rel="external">"Allergic reactions to local anesthetics", section on 'Common: Nonallergic reactions'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preparation</strong> – When <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> is used for local anesthesia during urgent or elective procedures, we suggest buffering with <a class="drug drug_general" data-topicid="9928" href="/z/d/drug information/9928.html" rel="external">sodium bicarbonate</a> and warming the anesthetic agent to approximately body temperature (37°C) prior to injection (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). Buffering of lidocaine may be of particular benefit for children or when injecting lidocaine with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>. (See <a class="local">'Methods to decrease injection pain'</a> above.)</p><p></p><p class="bulletIndent1">Other techniques to reduce the pain of injection may also be successful (see <a class="local">'Methods to decrease injection pain'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patient distraction (eg, television, mental imagery, and in children, books or toys [eg, pinwheel, blowing bubbles])</p><p class="bulletIndent2"><span class="glyph">•</span>Gentle pinching or vibration adjacent to the site of injection</p><p class="bulletIndent2"><span class="glyph">•</span>Use of small needles (25-, 27-, or 30-gauge)</p><p class="bulletIndent2"><span class="glyph">•</span>Slow rate of injection</p><p class="bulletIndent2"><span class="glyph">•</span>Subcutaneous instead of intradermal injection</p><p class="bulletIndent2"><span class="glyph">•</span>Reducing pressure of injection by using small-volume syringes (eg, 1 or 3 mL)</p><p class="bulletIndent2"><span class="glyph">•</span>Injecting with a needle angle of 90 rather than 45 degrees when penetrating intact skin for elective procedures (eg, skin biopsy)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Procedure</strong> – The techniques for direct infiltration of local anesthetics (infiltration through uninfected skin and clean lacerations) and field block (heavily contaminated lacerations or skin abscesses) are described above. (See <a class="local">'Direct infiltration'</a> above and <a class="local">'Field block'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic toxicity</strong> – Systemic toxicity, such as central nervous system effects (eg, metallic taste, paresthesia, confusion, lethargy, seizures) and cardiovascular effects (eg, bradycardia, atrioventricular block, ventricular arrhythmias, shock, or cardiac arrest), is unusual following subcutaneous local anesthetic infiltration but can occur if the recommended dose is exceeded, if a major vessel is inadvertently injected with a large amount of anesthetic, or as an idiosyncratic response. (See <a class="local">'Complications'</a> above.)</p><p></p><p class="bulletIndent1">The management of local anesthetic systemic toxicity is provided in the rapid overview  (<a class="graphic graphic_table graphicRef107887" href="/z/d/graphic/107887.html" rel="external">table 3</a>) and is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/90613.html" rel="external">"Local anesthetic systemic toxicity", section on 'Management of LAST'</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">McCreight, A, Stephan, M. Local and regional anesthesia. In: Textbook of Pediatric Emergency Procedures, 2nd edition, King, C, Henretig, FM (Eds), Lippincott, Williams, &amp; Wilkins, Philadelphia 2008. p.439.</li><li><a class="nounderline abstract_t">Tetzlaff JE. The pharmacology of local anesthetics. Anesthesiol Clin North America 2000; 18:217.</a></li><li class="breakAll">Yaster, M, Tobin, et al. Local anesthetics. In: Pain In Infants, Children, And Adolescents, 2nd edition, Schechter, NL, Berde, CB, Yaster, M (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia, PA 2003. p.241.</li><li><a class="nounderline abstract_t">Christoph RA, Buchanan L, Begalla K, Schwartz S. Pain reduction in local anesthetic administration through pH buffering. Ann Emerg Med 1988; 17:117.</a></li><li><a class="nounderline abstract_t">Berde CB. Toxicity of local anesthetics in infants and children. J Pediatr 1993; 122:S14.</a></li><li><a class="nounderline abstract_t">Ritchie JM, Ritchie B, Greengard P. The active structure of local anesthetics. J Pharmacol Exp Ther 1965; 150:152.</a></li><li><a class="nounderline abstract_t">Stanton-Hicks, MD . Local anesthetics: Pharmacology and clinical applications. Hosp Formul 1987; 22:156.</a></li><li><a class="nounderline abstract_t">Bartfield JM, Homer PJ, Ford DT, Sternklar P. Buffered lidocaine as a local anesthetic: an investigation of shelf life. Ann Emerg Med 1992; 21:16.</a></li><li><a class="nounderline abstract_t">Achar S, Kundu S. Principles of office anesthesia: part I. Infiltrative anesthesia. Am Fam Physician 2002; 66:91.</a></li><li><a class="nounderline abstract_t">Ahlstrom KK, Frodel JL. Local anesthetics for facial plastic procedures. Otolaryngol Clin North Am 2002; 35:29.</a></li><li><a class="nounderline abstract_t">Giovannitti JA, Bennett CR. Assessment of allergy to local anesthetics. J Am Dent Assoc 1979; 98:701.</a></li><li class="breakAll">McGee, DL. Local and topical anesthesia. In: Clinical Procedures In Emergency Medicine, 5th edition, Roberts, JR, Hedges, JR (Eds), Saunders Elsevier, Philadelphia 2010. p.481.</li><li><a class="nounderline abstract_t">Kaye AD, Fox CJ, Padnos IW, et al. Pharmacologic Considerations of Anesthetic Agents in Pediatric Patients: A Comprehensive Review. Anesthesiol Clin 2017; 35:e73.</a></li><li class="breakAll">Del Pizzo J, Fein JA, Selbst SM. Procedural sedation. In: Fleisher &amp; Ludwig's Textbook of Pediatric Emergency Medicine, 8th edition, Shaw KN, Bachur RG (Eds), Wolters Kluwer, Philadelphia, PA 2021. p.E129.</li><li><a class="nounderline abstract_t">Long B, Chavez S, Gottlieb M, et al. Local anesthetic systemic toxicity: A narrative review for emergency clinicians. Am J Emerg Med 2022; 59:42.</a></li><li><a class="nounderline abstract_t">Klotz U. Antiarrhythmics: elimination and dosage considerations in hepatic impairment. Clin Pharmacokinet 2007; 46:985.</a></li><li><a class="nounderline abstract_t">Kennedy RM, Luhmann JD. The "ouchless emergency department". Getting closer: advances in decreasing distress during painful procedures in the emergency department. Pediatr Clin North Am 1999; 46:1215.</a></li><li class="breakAll">Hruza, GJ. Anesthesia. In: Dermatology, 2nd, Bolognia, JL, Jorizzo, JL, Rapini, RP (Eds), Mosby Elsevier, Spain 2008. Vol 2, p.2173.</li><li><a class="nounderline abstract_t">Carraccio C, Feinberg P, Hart LS, et al. Lidocaine for lumbar punctures. A help not a hindrance. Arch Pediatr Adolesc Med 1996; 150:1044.</a></li><li><a class="nounderline abstract_t">Cooper DD, Seupaul RA. Does buffered lidocaine decrease the pain of local infiltration? Ann Emerg Med 2012; 59:281.</a></li><li><a class="nounderline abstract_t">Hogan ME, vanderVaart S, Perampaladas K, et al. Systematic review and meta-analysis of the effect of warming local anesthetics on injection pain. Ann Emerg Med 2011; 58:86.</a></li><li><a class="nounderline abstract_t">Cepeda MS, Tzortzopoulou A, Thackrey M, et al. Adjusting the pH of lidocaine for reducing pain on injection. Cochrane Database Syst Rev 2010; :CD006581.</a></li><li><a class="nounderline abstract_t">Martires KJ, Malbasa CL, Bordeaux JS. A randomized controlled crossover trial: lidocaine injected at a 90-degree angle causes less pain than lidocaine injected at a 45-degree angle. J Am Acad Dermatol 2011; 65:1231.</a></li></ol></div><div id="topicVersionRevision">Topic 6324 Version 44.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : McCreight, A, Stephan, M. Local and regional anesthesia. In: Textbook of Pediatric Emergency Procedures, 2nd edition, King, C, Henretig, FM (Eds), Lippincott, Williams, &amp; Wilkins, Philadelphia 2008. p.439.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10935008" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The pharmacology of local anesthetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10935008" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The pharmacology of local anesthetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2827545" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pain reduction in local anesthetic administration through pH buffering.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8487131" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Toxicity of local anesthetics in infants and children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5853695" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The active structure of local anesthetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Local anesthetics: Pharmacology and clinical applications</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1539881" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Buffered lidocaine as a local anesthetic: an investigation of shelf life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12126036" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Principles of office anesthesia: part I. Infiltrative anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11781206" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Local anesthetics for facial plastic procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/155708" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Assessment of allergy to local anesthetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/155708" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Assessment of allergy to local anesthetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28526162" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Pharmacologic Considerations of Anesthetic Agents in Pediatric Patients: A Comprehensive Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28526162" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pharmacologic Considerations of Anesthetic Agents in Pediatric Patients: A Comprehensive Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35777259" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Local anesthetic systemic toxicity: A narrative review for emergency clinicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18027986" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Antiarrhythmics: elimination and dosage considerations in hepatic impairment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10629683" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The "ouchless emergency department". Getting closer: advances in decreasing distress during painful procedures in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10629683" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The "ouchless emergency department". Getting closer: advances in decreasing distress during painful procedures in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8859136" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lidocaine for lumbar punctures. A help not a hindrance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21820761" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Does buffered lidocaine decrease the pain of local infiltration?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21316812" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Systematic review and meta-analysis of the effect of warming local anesthetics on injection pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21154371" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Adjusting the pH of lidocaine for reducing pain on injection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22082846" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : A randomized controlled crossover trial: lidocaine injected at a 90-degree angle causes less pain than lidocaine injected at a 45-degree angle.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
